Testing effectiveness (Phase 2)Study completedNCT02383810
What this trial is testing
Dose Finding Study in Colorectal Cancer Patients Receiving 5-FU-based Chemotherapy to Assess the Efficacy of Elsiglutide in the Prevention of Chemotherapy Induced Diarrhea (CID)
Who this might be right for
Drug and/or Toxin-induced Diarrhea
Helsinn Healthcare SA 498